Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Trulieve Cannabis (TCNNF) EBITDA Margin (2020 - 2026)

Trulieve Cannabis has reported EBITDA Margin over the past 6 years, most recently at 5.22% for Q4 2025.

  • For Q4 2025, EBITDA Margin rose 478.0% year-over-year to 5.22%; the TTM value through Dec 2025 reached 12.15%, up 391.0%, while the annual FY2025 figure was 16.64%, 652.0% up from the prior year.
  • EBITDA Margin for Q4 2025 was 5.22% at Trulieve Cannabis, down from 14.66% in the prior quarter.
  • Over five years, EBITDA Margin peaked at 40.33% in Q1 2021 and troughed at 103.37% in Q2 2023.
  • A 5-year average of 6.8% and a median of 13.63% in 2022 define the central range for EBITDA Margin.
  • Biggest five-year swings in EBITDA Margin: plummeted -12299bps in 2023 and later skyrocketed 11977bps in 2024.
  • Year by year, EBITDA Margin stood at 4.07% in 2021, then crashed by -66bps to 6.76% in 2022, then surged by 65bps to 2.38% in 2023, then soared by 118bps to 0.43% in 2024, then skyrocketed by 1101bps to 5.22% in 2025.
  • Business Quant data shows EBITDA Margin for TCNNF at 5.22% in Q4 2025, 14.66% in Q3 2025, and 17.42% in Q2 2025.